Palo Alto, California (PRWEB) May 16, 2016 -- At the Health Technology Forum Conference on May 22-23 at Stanford University, Dirk Boecker MD, PhD, CEO and co-founder of MassineBoecker, will discuss MAIKEVILLE, his firm’s innovative self-management support platform for individuals with chronic diseases.
MassineBoecker's automated yet personalized approach delivers outcomes that are significantly higher thanindustry averages (1).
The online platform uses proprietary, scientifically validated, psychological profiling tools to define and guide personalized interventions. With its adaptive low cost, high touch support MAIKEVILLE realizes sustained engagement over the long haul.
- Interventions address underlying emotional motivators and barriers
- Psychology based patient segmentation & stratification
- Focus on intuitive decision making with a holistic view of the individual
According to Dr. Boecker, "MAIKEVILLE builds on our 15 years of research in psychographic profiling and rule-based communication with a platform that delivers significant results for leading health organizations. These results include improvements in patient enrollment, program dropout rates, compliance with treatment regimens, and clinical outcomes".
MAIKEVILLE addresses the most critical self-management problems:
- Situational depression: the root cause of many treatment barriers
- Denial: Many patients with chronic diseases do not accept their health status
- Solution fatigue: Overwhelmed by an avalanche of health care apps and technologies
A new MAIKEVILLE patient starts with a short psychological survey that identifies his or her subconscious decision processes and behavioral barriers to a healthier lifestyle. Next, the system generates a personalized support plan. Then, most importantly, continuous support is provided to guide the patient in achieving long-term health gains.
MAIKEVILLE is an open, cloud based system that integrates with mobile apps, call centers and physician office software. Support modules for specific diseases and for diet, exercise, weight loss, stress reduction, sleep, etc. can be easily integrated. The system is currently used in an epidemiological study for people with diabetes by a top 5 pharmaceutical company and is under active consideration by leading health plans, mail order drug firms and organizations interested in improving population health management.
(1) For example: Improved clinical outcomes up to 20%; reduced dropout rates up to 15%; increased enrollment in support programs up to 45%
MassineBoecker operates its business through two locations in Palo Alto, CA and Berlin, Germany. The company
is privately held and has proven its approach through several projects with top tier payers and customers in pharma, diagnostics, and with mail order pharmacies. The company is led by an internationally experienced management team and benefits from industry leading advisors. http://www.massineboecker.com
About HTF (Health Technology Forum)
HTF is a platform for people worldwide who have a common interest in making healthcare better, more accessible and affordable. Our international network of technology and healthcare entrepreneurs, developers, regulators, and providers are advancing the pace of healthcare innovation by engaging in exciting and productive dialogue between experts in healthcare. http://healthtechnologyforum.com/2016-htf-innovation-conference/
For more information, please contact info(at)massineboecker(dot)com
Dirk Boecker, MassineBoecker, http://www.massineboecker.com, +1 814 737 7664, [email protected]